Symetryx Corp - Net Worth and Insider Trading

Symetryx Corp Net Worth

The estimated net worth of Symetryx Corp is at least $0 dollars as of 2024-11-05. Symetryx Corp is the 10% Owner of NeuBase Therapeutics Inc and owns about 0 shares of NeuBase Therapeutics Inc (NBSE) stock worth over $0. Details can be seen in Symetryx Corp's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Symetryx Corp has not made any transactions after 2023-09-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Symetryx Corp

To

Symetryx Corp Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Symetryx Corp owns 1 companies in total, including NeuBase Therapeutics Inc (NBSE) .

Click here to see the complete history of Symetryx Corp’s form 4 insider trades.

Insider Ownership Summary of Symetryx Corp

Ticker Comapny Transaction Date Type of Owner
NBSE NeuBase Therapeutics Inc 2023-09-18 10 percent owner

Symetryx Corp Latest Holdings Summary

Symetryx Corp currently owns a total of 1 stock. Symetryx Corp owns 0 shares of NeuBase Therapeutics Inc (NBSE) as of September 18, 2023, with a value of $0.

Latest Holdings of Symetryx Corp

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
NBSE NeuBase Therapeutics Inc 2023-09-18 0 0.38 0

Holding Weightings of Symetryx Corp


Symetryx Corp Form 4 Trading Tracker

According to the SEC Form 4 filings, Symetryx Corp has made a total of 3 transactions in NeuBase Therapeutics Inc (NBSE) over the past 5 years, including 1 buys and 2 sells. The most-recent trade in NeuBase Therapeutics Inc is the sale of 282,445 shares on September 18, 2023, which brought Symetryx Corp around $375,652.

Insider Trading History of Symetryx Corp

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Symetryx Corp Trading Performance

GuruFocus tracks the stock performance after each of Symetryx Corp's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Symetryx Corp is -2.97%. GuruFocus also compares Symetryx Corp's trading performance to market benchmark return within the same time period. The performance of stocks bought by Symetryx Corp within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Symetryx Corp's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Symetryx Corp

Average Return

No transaction record over 1 Year.

Outperforming Transactions

No transaction record over 1 Year.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -7.26 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -2.22 LIMIT LIMIT LIMIT LIMIT LIMIT

Symetryx Corp Ownership Network

Ownership Network List of Symetryx Corp

No Data

Ownership Network Relation of Symetryx Corp

Insider Network Chart

Symetryx Corp Owned Company Details

What does NeuBase Therapeutics Inc do?

Who are the key executives at NeuBase Therapeutics Inc?

Symetryx Corp is the 10 percent owner of NeuBase Therapeutics Inc. Other key executives at NeuBase Therapeutics Inc include 10 percent owner Barry Shiff , 10 percent owner Aleta Shiff , and COO William Roland Mann .

NeuBase Therapeutics Inc (NBSE) Insider Trades Summary

Over the past 18 months, Symetryx Corp made 3 insider transaction in NeuBase Therapeutics Inc (NBSE) with a net sale of 428,444.

In summary, during the past 3 months, insiders sold 0 shares of NeuBase Therapeutics Inc (NBSE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 489,520 shares of NeuBase Therapeutics Inc (NBSE) were sold and 61,076 shares were bought by its insiders, resulting in a net sale of 428,444 shares.

NeuBase Therapeutics Inc (NBSE)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

NeuBase Therapeutics Inc Insider Transactions

No Available Data

Symetryx Corp Mailing Address

Above is the net worth, insider trading, and ownership report for Symetryx Corp. You might contact Symetryx Corp via mailing address: 2828 Bathurst St #400, Toronto A6 M6b3a7.